IDA total vs Latvia: Cause of death, by non-communicable diseases, ages 15-59, male
IDA total
42.1%
in 2021
Latvia
68.8%
in 2021
IDA total rank
34th
Latvia rank
35th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- IDA total
- Latvia
How they compare
Latvia currently reports 68.8% against 42.1% in IDA total, a difference of 26.7%.
That makes Latvia's figure about 1.6 times IDA total's.
Across all 6 years both countries report, Latvia has been ahead every year.
IDA total ranks 34th and Latvia ranks 35th of 47 groups.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.3% | 58.5% | 23.2% | Latvia |
| 2010s | 42.9% | 70.1% | 27.2% | Latvia |
| 2020s | 43.2% | 70.3% | 27.1% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, IDA total or Latvia?
- Latvia, at 68.8% against 42.1% in IDA total as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between IDA total and Latvia?
- 26.7%, with Latvia ahead.
- How many years of comparable data are there for IDA total and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA total and Latvia rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- IDA total ranks 34th and Latvia ranks 35th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.